Editorial Comment to “Clinical Features and Risk Factors of Enfortumab Vedotin‐Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study ( YUSHIMA Study)”

International Journal of Urology 2026

View at publisher

Authors: Makito Miyake

DOI: 10.1111/iju.70351

Cited by: 0

References: 3

Fields of Study & Subjects

Cancer Treatment and Pharmacology Bladder and Urothelial Cancer Treatments Chemotherapy-related skin toxicity

References 3